SEMPREX-D Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Semprex-d, and what generic alternatives are available?
Semprex-d is a drug marketed by Auxilium Pharms Llc and is included in one NDA.
The generic ingredient in SEMPREX-D is acrivastine; pseudoephedrine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the acrivastine; pseudoephedrine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SEMPREX-D?
- What are the global sales for SEMPREX-D?
- What is Average Wholesale Price for SEMPREX-D?
Summary for SEMPREX-D
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Patent Applications: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SEMPREX-D |
DailyMed Link: | SEMPREX-D at DailyMed |
![SEMPREX-D drug patent expirations Drug patent expirations by year for SEMPREX-D](/p/graph/s/t/SEMPREX-D-patent-expirations.png)
![Drug Prices for SEMPREX-D](/p/graph/drug-price/SEMPREX-D.png)
US Patents and Regulatory Information for SEMPREX-D
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Auxilium Pharms Llc | SEMPREX-D | acrivastine; pseudoephedrine hydrochloride | CAPSULE;ORAL | 019806-001 | Mar 25, 1994 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SEMPREX-D
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Auxilium Pharms Llc | SEMPREX-D | acrivastine; pseudoephedrine hydrochloride | CAPSULE;ORAL | 019806-001 | Mar 25, 1994 | ⤷ Sign Up | ⤷ Sign Up |
Auxilium Pharms Llc | SEMPREX-D | acrivastine; pseudoephedrine hydrochloride | CAPSULE;ORAL | 019806-001 | Mar 25, 1994 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SEMPREX-D
See the table below for patents covering SEMPREX-D around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hungary | 189223 | PROCESS FOR PREPARING 3,3-DIPHENYL- AND 3-PYRIDYL-3-PHENYL-PROPYL- AND PROPENYL-AMINE-DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH ACTIVE SUBSTANCE | ⤷ Sign Up |
Austria | 64596 | ⤷ Sign Up | |
Spain | 523414 | ⤷ Sign Up | |
Netherlands | 930057 | ⤷ Sign Up | |
Spain | 519491 | ⤷ Sign Up | |
Yugoslavia | 22183 | ⤷ Sign Up | |
Japan | H0153671 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SEMPREX-D
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0085959 | SPC/GB93/090 | United Kingdom | ⤷ Sign Up | SPC/GB93/090, EXPIRES: 20051230 |
0085959 | SPC/GB93/019 | United Kingdom | ⤷ Sign Up | SPC/GB93/019, EXPIRES: 20030922 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |